GeneDx Holdings Corp. (WGSWW)
- Previous Close
0.1300 - Open
0.2371 - Bid --
- Ask --
- Day's Range
0.1185 - 0.3380 - 52 Week Range
0.1185 - 0.3380 - Volume
397,497 - Avg. Volume
-- - Market Cap (intraday)
-- - Beta (5Y Monthly) 2.38
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.
www.genedx.com1,000
Full Time Employees
--
Fiscal Year Ends
Sector
Industry
Recent News: WGSWW
View More
Compare To: WGSWW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WGSWW
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-48.21%
Return on Assets (ttm)
-12.20%
Return on Equity (ttm)
-47.93%
Revenue (ttm)
243.66M
Net Income Avi to Common (ttm)
-117.47M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
106.86M
Total Debt/Equity (mrq)
60.28%
Levered Free Cash Flow (ttm)
-48.04M
Company Insights: WGSWW
WGSWW does not have Company Insights